You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stem cell transplantation

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TGCT Trial in Washington, Baltimore (Emactuzumab, Placebo)

Active, not recruiting
  • TGCT
  • Washington, District of Columbia
  • +1 more
Sep 23, 2022

Myocardial Infarction Trial in Canada, United States (Prochymal®, Placebo)

Completed
  • Myocardial Infarction
  • Gilbert, Arizona
  • +32 more
Jan 11, 2022

Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A

Recruiting
  • Autoimmune Diseases
  • +5 more
  • CT103A cells
  • Cyclophosphamide and fludarabine
  • Wuhan, Hubei, China
    Tongji Hospital affiliated to Tongji Medical College of Huazhong
Dec 10, 2022

Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma Trial in Aventura, Brandon, Webster (EscharEx 5% (EX-02

Recruiting
  • Superficial Basal Cell Carcinoma
  • Nodular Basal Cell Carcinoma
  • EscharEx 5% (EX-02 formulation)
  • Aventura, Florida
  • +2 more
Dec 1, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Head Neck Cancer Trial in Madison (NKTR-214, anti-PD-1 therapy, Palliative Radiation)

Active, not recruiting
  • Head and Neck Cancer
  • Madison, Wisconsin
    University of Wisconsin
May 9, 2022

Spontaneous Regression in Metastatic Melanoma and Renal Cell

Active, not recruiting
  • Melanoma; Renal Cell Carcinoma
  • Blood collection for laboratory studies
  • Data collection from medical record
  • Indianapolis, Indiana
    Indiana University Simon Cancer Center
Apr 1, 2022

Sarcoidosis With Myocarditis, Sarcoidosis, Healthy Trial in Iowa City (cell free DNA)

Recruiting
  • Sarcoidosis With Myocarditis
  • +3 more
  • cell free DNA
  • Iowa City, Iowa
  • +1 more
May 16, 2022

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

Completed
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 27, 2022

Huaier Granules in Postoperative Adjuvant Therapy for Non-small

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Huaier granule
  • Control
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital & Institute
Oct 27, 2023

Advanced Lung Adenocarcinoma, Advanced Lung Adenosquamous Carcinoma, Advanced Lung Non-Small Cell Carcinoma Trial in United

Recruiting
  • Advanced Lung Adenocarcinoma
  • +10 more
  • Phoenix, Arizona
  • +98 more
Feb 2, 2023

Alterations in CD8aß and CD8aa T Cell Levels in Rheumatoid

Not yet recruiting
  • Rheumatoid Arthritis
  • flow cytometry
  • (no location specified)
Apr 12, 2023

Lung Cancer, Non-Small Cell Trial in Worldwide (Cobolimab, Dostarlimab, Docetaxel)

Recruiting
  • Lung Cancer, Non-Small Cell
  • Cobolimab
  • +2 more
  • Fountain Valley, California
  • +106 more
Apr 12, 2022

Esophageal Squamous Cell Carcinomas Trial (PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1

Not yet recruiting
  • Esophageal Squamous Cell Carcinomas
  • PF regimen (cis-platinum ; 5-fluorouracil ) combined with PD-1 inhibitors（pembrolizumab）
  • (no location specified)
Nov 1, 2021

B-cell Lymphoma Trial in Sanhe (CD19/CD20 Dual-CAR-T cells)

Completed
  • B-cell Lymphoma
  • CD19/CD20 Dual-CAR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Mar 6, 2022

B-cell Leukemia Trial in Sanhe (CD19/CD20 Dual-CAR-T cells)

Completed
  • B-cell Leukemia
  • CD19/CD20 Dual-CAR-T cells
  • Sanhe, Hebei, China
    Hebei Yanda Ludaopei Hospital
Mar 6, 2022

Multiple Myeloma Cells From miRNAs Released From B Cells, and

Recruiting
  • Multiple Myeloma
    • Aviano, Pordenone, Italy
      Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
    Nov 23, 2023

    Early Supraglottic Squamous Cell Carcinoma With Advance

    Recruiting
    • Supraglottic Squamous Cell Carcinoma
    • Early Stage (T1-T2, N0-N1,M0)
    • TORS
    • Yvoir, Namur, Belgium
      CHU UCL Namur
    Nov 3, 2022

    T-cell Lymphoma, Relapsed and Refractory T-cell Lymphoma Trial in New York, Columbus (Ibrutinib)

    Active, not recruiting
    • T-cell Lymphoma
    • Relapsed and Refractory T-cell Lymphoma
    • New York, New York
    • +1 more
    Nov 8, 2022

    Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)

    Recruiting
    • Lung Cancer
    • Olaparib+Bevacizumab to SCLC patients
    • Seoul, Gangnam-gu, Korea, Republic of
    • +3 more
    Nov 9, 2022

    Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Worldwide (JNJ-74856665, AZA, VEN)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Birmingham, Alabama
    • +22 more
    Jan 27, 2023

    IL-23-Responsive Immune Cell Subsets in Post-Operative

    Recruiting
    • Crohn´s Disease
      • Amsterdam, Noord-Holland, Netherlands
        Amsterdam UMC
      Aug 16, 2023

      Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

      Completed
      • Non-small Cell Lung Cancer
      • Calgary, Alberta, Canada
      • +4 more
      Jun 28, 2023

      Hemorrhage Trial in Porto Alegre (Tranexamic acid)

      Recruiting
      • Hemorrhage
      • Tranexamic acid
      • Porto Alegre, RS, Brazil
        Andre Prato Schmidt
      Aug 24, 2021

      Esophageal Squamous Cell Carcinoma (ESCC) Trial in China (Tislelizumab, Placebo, Paclitaxel)

      Active, not recruiting
      • Esophageal Squamous Cell Carcinoma (ESCC)
      • Beijing, Beijing, China
      • +31 more
      Mar 1, 2022